Venture Certified
| 혁신성장유형 | 2025-11-05 ~ 2028-11-04 | 20251105030051 | 2025-11-05 |
Revenue CAGR -59.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.4B | 2.5B | 2.5B |
| Operating Profit | -1.9B | -1.5B | 0.3B |
| Net Profit | -1.9B | -1.5B | 0.9B |
| Total Assets | 1.8B | 4.8B | 5.5B |
| Total Liabilities | 2.9B | 3.9B | 3.2B |
| Total Equity | -1.1B | 0.8B | 2.3B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -2B
Revenue down 84% YoY
2 Consecutive Years of Net Loss
▼ 83.6%
▼ 215.4%
▼ 1849.5%
▼ 184.0%
▲ 352.6%
| Name | Position | Role |
|---|---|---|
| 고재윤 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대구광역시 동구",
"ceo_name": "고재윤",
"certificate": [
{
"cert_number": "20251105030051",
"changes": "",
"disclosure_date": "2025-11-05",
"first_cert_date": "2025-11-05",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2025-11-05 ~ 2028-11-04"
}
],
"company_name": "(주)비엘에스씨피",
"corp_no": "170111-*******",
"financials": {
"2022": {
"capital_stock": 100000000,
"cost_of_sales": 133578000,
"current_assets": 481842000,
"current_liabilities": 20383000,
"gross_profit": 113566000,
"net_income": 89133000,
"net_income_bs": 82973000,
"non_current_assets": 67180000,
"non_current_liabilities": 299321000,
"non_operating_expenses": 7887000,
"non_operating_income": 65883000,
"operating_profit": 31137000,
"revenue": 247144000,
"sga_expenses": 82428000,
"total_assets": 549022000,
"total_equity": 229318000,
"total_liabilities": 319704000
},
"2023": {
"capital_stock": 100000000,
"cost_of_sales": 284069000,
"current_assets": 412915000,
"current_liabilities": 91000000,
"gross_profit": -33255000,
"net_income": -146451000,
"net_income_bs": -146616000,
"non_current_assets": 63403000,
"non_current_liabilities": 302616000,
"non_operating_expenses": 12067000,
"non_operating_income": 19159000,
"operating_profit": -153543000,
"revenue": 250814000,
"sga_expenses": 120288000,
"total_assets": 476318000,
"total_equity": 82702000,
"total_liabilities": 393617000
},
"2024": {
"capital_stock": 100000000,
"cost_of_sales": 176468000,
"current_assets": 126941000,
"current_liabilities": 10687000,
"gross_profit": -135740000,
"net_income": -193566000,
"net_income_bs": -193566000,
"non_current_assets": 48885000,
"non_current_liabilities": 276004000,
"non_operating_expenses": 10421000,
"non_operating_income": 9870000,
"operating_profit": -193015000,
"revenue": 40727000,
"sga_expenses": 57274000,
"total_assets": 175827000,
"total_equity": -110864000,
"total_liabilities": 286691000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [],
"main_products": "재활보조기기 및 장비",
"phone": "053-214-****",
"years": [
2024,
2023,
2022
]
}